Literature DB >> 26686561

Optimisation and establishment of separation conditions of organic acids from Usnea longissima Ach. by pH-zone-refining counter-current chromatography: Discussion of the eluotropic sequence.

Changlei Sun1, Feng Liu2, Jie Sun2, Jia Li3, Xiao Wang4.   

Abstract

The major bioactive constituents of Usnea longissima Ach. are organic acids. However, few recent literatures involve the preparative separation of these organic acids. In the present study, pH zone-refining counter-current chromatography is used to separate organic acids from crude sample of U. longissima Ach. The crude extract was separated with the two-phase solvent system Pet-EtAc-MeOH-H2O (5:5:3:7, v/v) with 10mM TFA in organic stationary phase and different concentration of the eluter in aqueous mobile phase for the screening of the most suitable separation conditions. From the crude extract (1.2g), 74.0mg of orsellinic acid at 92.7% purity, 55.5mg of 4-O-methylorsellinic acid at 97.7% purity, 353.5mg of evernic acid at 93.8% purity, 102.0mg of barbatic acid at 94.8% purity, 19.4 mg of diffractaic acid at 92.2% purity, and 44.9 mg of usnic acid at 95.7% purity were obtained using the selected conditions in which the concentration of TFA in stationary phase was 10mM and the concentration of NaOH in mobile phase was 10-20mM. The purities of the separated organic acids were measured by HPLC. And the data of electrospray ionization-liquid chromatography/mass spectrometry (ESI-LC/MS), (1)H NMR, and (13)C NMR were used for confirming chemical structures.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Eluotropic sequence; Organic acids; Usnea longissima Ach.; pH-zone-refining counter-current chromatography

Mesh:

Substances:

Year:  2015        PMID: 26686561     DOI: 10.1016/j.chroma.2015.12.016

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  A multilayer coil in type-I counter-current chromatography.

Authors:  Yi Yang; Jiao Yang; Chen Fang; Dongyu Gu; Ying Ma; Yoichiro Ito
Journal:  J Chromatogr A       Date:  2018-02-13       Impact factor: 4.759

2.  pH-Zone-refining counter-current chromatography for two new lipo-alkaloids separated from refined alkaline extraction of Kusnezoff monkshood root.

Authors:  Jiadi Zhao; Peihe Li; Zhong Zheng; Zifeng Pi; Liang Xu; Limei Duan; Wuliji Ao; Xiaowen Sun; Zhiqiang Liu; Jinghai Liu
Journal:  J Sep Sci       Date:  2020-04-08       Impact factor: 3.645

3.  A Strategy for Preparative Separation of 10 Lignans from Justicia procumbens L. by High-Speed Counter-Current Chromatography.

Authors:  Jiaojiao Jiang; Hongjing Dong; Tao Wang; Ruixuan Zhao; Yan Mu; Yanling Geng; Zhenjia Zheng; Xiao Wang
Journal:  Molecules       Date:  2017-11-23       Impact factor: 4.411

4.  Preparative separation of structural isomeric pentacyclic triterpene oleanolic acid and ursolic acid from natural products by pH-zone-refining countercurrent chromatography.

Authors:  Chaoyue Wang; Xiang Wang; Shanshan Zhao; Wenyu Sun; Shengqiang Tong
Journal:  RSC Adv       Date:  2019-11-27       Impact factor: 4.036

5.  Diversity of endophytic bacterial and fungal microbiota associated with the medicinal lichen Usnea longissima at high altitudes.

Authors:  Qi Wang; Jun Li; Jie Yang; Yue Zou; Xin-Qing Zhao
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

6.  Counter-Current Fractionation-Assisted Bioassay-Guided Separation of Active Compound from Blueberry and the Interaction between the Active Compound and α-Glucosidase.

Authors:  Hongkun Xue; Xiaohan Zhu; Jiaqi Tan; Linlin Fan; Qian Li; Jintian Tang; Xu Cai
Journal:  Foods       Date:  2021-03-01

Review 7.  A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine.

Authors:  Haiyu Xu; Yanqiong Zhang; Ping Wang; Junhong Zhang; Hong Chen; Luoqi Zhang; Xia Du; Chunhui Zhao; Dan Wu; Feng Liu; Hongjun Yang; Changxiao Liu
Journal:  Acta Pharm Sin B       Date:  2021-03-20       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.